Literature DB >> 24503852

A structurally distinct human mycoplasma protein that generically blocks antigen-antibody union.

Rajesh K Grover1,2, Xueyong Zhu3, Travis Nieusma3, Teresa Jones1, Isabel Boreo1, Amanda S MacLeod4, Adam Mark5, Sherry Niessen6, Helen J Kim3, Leopold Kong3, Nacyra Assad-Garcia7, Keehwan Kwon7, Marta Chesi8, Vaughn V Smider1, Daniel R Salomon5, Diane F Jelinek9, Robert A Kyle9, Richard B Pyles10, John I Glass7, Andrew B Ward3, Ian A Wilson3,11, Richard A Lerner1,2.   

Abstract

We report the discovery of a broadly reactive antibody-binding protein (Protein M) from human mycoplasma. The crystal structure of the ectodomain of transmembrane Protein M differs from other known protein structures, as does its mechanism of antibody binding. Protein M binds with high affinity to all types of human and nonhuman immunoglobulin G, predominantly through attachment to the conserved portions of the variable region of the κ and λ light chains. Protein M blocks antibody-antigen union, likely because of its large C-terminal domain extending over the antibody-combining site, blocking entry to large antigens. Similar to the other immunoglobulin-binding proteins such as Protein A, Protein M as well as its orthologs in other Mycoplasma species could become invaluable reagents in the antibody field.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24503852      PMCID: PMC3987992          DOI: 10.1126/science.1246135

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  23 in total

1.  Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity.

Authors:  M Graille; E A Stura; A L Corper; B J Sutton; M J Taussig; J B Charbonnier; G J Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 2.  Interaction of mycoplasmas with host cells.

Authors:  Shlomo Rottem
Journal:  Physiol Rev       Date:  2003-04       Impact factor: 37.312

3.  Vesicoureteral reflux after kidney transplantation: clinical significance in the medium to long-term.

Authors:  A Vianello; G Pignata; C Caldato; G Di Falco; G Calconi; A Fandella; A Rabassini; M C Maresca
Journal:  Clin Nephrol       Date:  1997-06       Impact factor: 0.975

4.  A novel, highly stable fold of the immunoglobulin binding domain of streptococcal protein G.

Authors:  A M Gronenborn; D R Filpula; N Z Essig; A Achari; M Whitlow; P T Wingfield; G M Clore
Journal:  Science       Date:  1991-08-09       Impact factor: 47.728

Review 5.  Murine models of systemic lupus erythematosus.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

6.  The third IgG-binding domain from streptococcal protein G. An analysis by X-ray crystallography of the structure alone and in a complex with Fab.

Authors:  J P Derrick; D B Wigley
Journal:  J Mol Biol       Date:  1994-11-11       Impact factor: 5.469

7.  Epitopes involved in antibody-mediated protection from Ebola virus.

Authors:  J A Wilson; M Hevey; R Bakken; S Guest; M Bray; A L Schmaljohn; M K Hart
Journal:  Science       Date:  2000-03-03       Impact factor: 47.728

8.  Complex between Peptostreptococcus magnus protein L and a human antibody reveals structural convergence in the interaction modes of Fab binding proteins.

Authors:  M Graille; E A Stura; N G Housden; J A Beckingham; S P Bottomley; D Beale; M J Taussig; B J Sutton; M G Gore; J B Charbonnier
Journal:  Structure       Date:  2001-08       Impact factor: 5.006

9.  Glomerular basement membrane. Identification of dimeric subunits of the noncollagenous domain (hexamer) of collagen IV and the Goodpasture antigen.

Authors:  S Gunwar; F Ballester; R Kalluri; J Timoneda; A M Chonko; S J Edwards; M E Noelken; B G Hudson
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

10.  Prediction of molecular mimicry candidates in human pathogenic bacteria.

Authors:  Andrew C Doxey; Brendan J McConkey
Journal:  Virulence       Date:  2013-05-28       Impact factor: 5.882

View more
  31 in total

1.  Antibody modeling using the prediction of immunoglobulin structure (PIGS) web server [corrected].

Authors:  Paolo Marcatili; Pier Paolo Olimpieri; Anna Chailyan; Anna Tramontano
Journal:  Nat Protoc       Date:  2014-11-06       Impact factor: 13.491

Review 2.  Considerations for the Design of Antibody-Based Therapeutics.

Authors:  Dennis R Goulet; William M Atkins
Journal:  J Pharm Sci       Date:  2019-06-04       Impact factor: 3.534

3.  Identification of a novel Picornavirales virus distantly related to posavirus in swine feces.

Authors:  Ben M Hause; Richard A Hesse; Gary A Anderson
Journal:  Virus Genes       Date:  2015-06-02       Impact factor: 2.332

4.  Applications for an engineered Protein-G variant with a pH controllable affinity to antibody fragments.

Authors:  Lucas J Bailey; Kimberly M Sheehy; Robert J Hoey; Zachary P Schaefer; Marcin Ura; Anthony A Kossiakoff
Journal:  J Immunol Methods       Date:  2014-10-22       Impact factor: 2.303

Review 5.  The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability.

Authors:  Gerwyn Morris; Michael Berk; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

6.  The molecular characterization of antibody binding to a superantigen-like protein from a commensal microbe.

Authors:  Marta T Borowska; Christoph Drees; Alexander E Yarawsky; Mayuri Viswanathan; Sean M Ryan; Jeffrey J Bunker; Andrew B Herr; Albert Bendelac; Erin J Adams
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-28       Impact factor: 11.205

7.  MIB-MIP is a mycoplasma system that captures and cleaves immunoglobulin G.

Authors:  Yonathan Arfi; Laetitia Minder; Carmelo Di Primo; Aline Le Roy; Christine Ebel; Laurent Coquet; Stephane Claverol; Sanjay Vashee; Joerg Jores; Alain Blanchard; Pascal Sirand-Pugnet
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

Review 8.  Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs.

Authors:  Dominiek Maes; Filip Boyen; Bert Devriendt; Peter Kuhnert; Artur Summerfield; Freddy Haesebrouck
Journal:  Vet Res       Date:  2021-05-08       Impact factor: 3.683

9.  Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2.

Authors:  Fred D Mast; Peter C Fridy; Natalia E Ketaren; Junjie Wang; Erica Y Jacobs; Jean Paul Olivier; Tanmoy Sanyal; Kelly R Molloy; Fabian Schmidt; Magda Rutkowska; Yiska Weisblum; Lucille M Rich; Elizabeth R Vanderwall; Nicolas Dambrauskas; Vladimir Vigdorovich; Sarah Keegan; Jacob B Jiler; Milana E Stein; Paul Dominic B Olinares; Theodora Hatziioannou; D Noah Sather; Jason S Debley; David Fenyö; Andrej Sali; Paul D Bieniasz; John D Aitchison; Brian T Chait; Michael P Rout
Journal:  bioRxiv       Date:  2021-04-10

10.  Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape.

Authors:  Fred D Mast; Peter C Fridy; Natalia E Ketaren; Junjie Wang; Erica Y Jacobs; Jean Paul Olivier; Tanmoy Sanyal; Kelly R Molloy; Fabian Schmidt; Magdalena Rutkowska; Yiska Weisblum; Lucille M Rich; Elizabeth R Vanderwall; Nicholas Dambrauskas; Vladimir Vigdorovich; Sarah Keegan; Jacob B Jiler; Milana E Stein; Paul Dominic B Olinares; Louis Herlands; Theodora Hatziioannou; D Noah Sather; Jason S Debley; David Fenyö; Andrej Sali; Paul D Bieniasz; John D Aitchison; Brian T Chait; Michael P Rout
Journal:  Elife       Date:  2021-12-07       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.